Xinjiang Longhuiyuan Pharmaceutical Co., Ltd. (新疆隆惠源药业有限公司) is a China-based pharmaceutical trading and distribution company primarily engaged in the importation and supply of pharmaceutical products. The company operates within the pharmaceutical supply chain and is known for its role as an importer and distributor of various medicinal products in the Chinese market.
Established in the Xinjiang region, a strategically significant area in northwestern China, Longhuiyuan Pharmaceutical leverages its geographical advantage to facilitate cross-border pharmaceutical trade, especially with Central Asia. The company plays a crucial role in supplying high-demand drugs and healthcare products to the Xinjiang province, where access to pharmaceutical infrastructure has seen significant development in recent years.
Core Business
The core business of Xinjiang Longhuiyuan Pharmaceutical lies in:
- Importation of pharmaceutical products, particularly formulations and raw materials from international suppliers.
- Distribution of medicines within the domestic Chinese market, focusing on the Xinjiang region.
- Wholesale pharmaceutical operations, including the coordination of logistics and regulatory compliance for imported drugs.
Product and Service Offerings
While detailed product categories are not explicitly listed in public databases, import-export trade data indicates that the company has dealt with:
- Human pharmaceutical preparations
- Medical compounds and formulations
- Active Pharmaceutical Ingredients (APIs)
The company primarily acts as a channel partner for international pharmaceutical manufacturers seeking entry into Western China.
Specialization and Core USP
Xinjiang Longhuiyuan Pharmaceutical specializes in navigating China's import regulations and customs procedures, particularly in the less saturated pharmaceutical market of the Xinjiang region. Its core USPs include:
- Geographical strategic location for cross-border trade
- Strong regulatory compliance management
- Efficient distribution networks in Western China
Financials
Specific revenue or profit details for the company are not publicly disclosed due to its private company status and lack of open financial filings. However, based on trade activity, the company appears to have a consistent and focused niche in pharmaceutical importation.
Shipment Data
According to shipment records from Volza and ImportYeti:
- Company: Xinjiang Longhuiyuan Pharmaceutical Co., Ltd.
- Number of recorded international shipments: 27 (over a 24-month period)
- Top countries shipped from: India, Germany
- Imported products: Finished pharmaceutical products, oral solid dosage formulations, injectable medicines
These figures validate the company’s operational activity in pharmaceutical trade.
Target Market
The company's primary market includes:
- Hospitals and clinics across Xinjiang and neighboring provinces
- Pharmacies and medical supply retailers
- Healthcare institutions and distributors in Central Asia (indirectly via re-export channels)
Capabilities
Xinjiang Longhuiyuan Pharmaceutical has demonstrated the following capabilities:
- Managing international procurement contracts
- Handling pharmaceutical import certifications and drug registration protocols
- Operating within regulated distribution frameworks under China FDA oversight
Certifications and Compliance
Though direct listings of certifications are unavailable, given the nature of pharmaceutical importation in China, the company is required to comply with:
- GSP (Good Supply Practice) certifications
- CFDA (China Food and Drug Administration) import permits
- Customs and quarantine compliance at land and air ports in Xinjiang
These compliance layers are mandatory for any pharmaceutical importer operating in China.
Customer Testimonials
No publicly available customer testimonials could be sourced from company-owned platforms or third-party directories. As a B2B-focused operation, direct customer-facing reviews may be limited.
Major Achievements
- Established a cross-border pharmaceutical import channel in Xinjiang—one of the few companies operating in this niche region.
- Built a reliable import record from major pharmaceutical hubs like India and Germany, as evidenced by consistent trade data entries.
- Contributed to improved pharmaceutical access in less-developed regions of China through sustained supply efforts.